”Most of the drugs that are part of COVID-19 management protocol have ceiling prices, viz., paracetamol, dexamethasone, methylprednisolone, IVIGs, enoxaparin, budesonide, heparin and amphotericin, etc,” Minister of Chemicals and Fertilisers Mansukh Mandaviya said in a written reply to a query in the Lok Sabha.
In the case of few non-scheduled medicines like remdesivir, which are part of COVID-19 protocol and are non-scheduled, on government intervention, MRPs of various brands of remdesivir have been reduced voluntarily by the major manufacturers/marketers of the remdesivir injection (lyophilized), he added.
Inter-brand maximum retail prices (MRPs) that varied up to Rs 5,400 per vial were brought down to less than Rs 3,500, the minister said.
Category:
Health
Latest
ICICI Lombard and Dr. Reddy’s collaborate for pilot launch of cashless digital health solution
Users will benefit from cashless access to consultation from leading doctors and healthcare professionals across specialisations and geographies, pathology laboratories and diagnostic services, pharmacies, and a comprehensive support centre, all on a simple, easily accessible mobile platform. It offers options of in-person as well as remote tele/video consultations, home sample collections and medicine deliveries, digital health record management and a comprehensive support and fulfilment system.
WHO has commenced review process for emergency use listing of Covaxin: Govt
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.